Playback speed
10 seconds
Is Immunotherapy Ineffective for Driver Mutation-positive Advanced NSCLC?
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
0 views
November 2, 2018
Dr. Jack West summarizes the evolving data shaping our understanding of the role of immune ...
read more ↘ checkpoint inhibitors for patients with EGFR- or ALK-positive advanced NSCLC, including more recent data that should change our perspective.
↖ read less
read more ↘ checkpoint inhibitors for patients with EGFR- or ALK-positive advanced NSCLC, including more recent data that should change our perspective.
↖ read less
Comments 1
Login to view comments.
Click here to Login
Lung